Unibest
← Back to patent-cliff list

Taniborbactam

Tier C — Watch / trade

Taniborbactam

Venatorx Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Beta Lactamase

Indications (approved):Urinary tract infection, Pyelonephritis

Regional status

US
-
EU
-
China
Phase III
2019-08-17
Japan
-

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 10 · Total yield 10mg (Taniborbactam)
Tani-00126507-91-5Tani-0022377377-83-6Tani-0032377377-87-0Tani-0041613269-60-5Tani-0052407879-39-2Tani-0062407879-41-6Tani-0071613269-64-9Tani-0082407879-42-7Tani-00976308-28-6Tani-01039684-80-5Tani-0111613269-84-3Tani-0121613269-62-7API · Taniborbactam
CodeCAS No.Intermediate
Tani-00126507-91-52-methoxy-3-methylbenzoic acid
Tani-0022377377-83-6tert-butyl 2-methoxy-3-methylbenzoate
Tani-0032377377-87-0tert-butyl 3-(bromomethyl)-2-methoxybenzoate
Tani-0041613269-60-5Benzoic acid, 3-[[(3aR,4R,6R,7aS)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]methyl]-2-methoxy-, 1,1-dimethylethyl ester
Tani-0052407879-39-2Benzoic acid, 3-[(2S )-2-chloro-2-[(3aR ,4R ,6R ,7aS )-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl]-2- methoxy-, 1,1-dimethylethyl ester
Tani-0062407879-41-6Benzoic acid, 3-[(2R )-2-amino-2-[(3aR ,4R ,6R ,7aS )-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl]-2- methoxy-, 1,1-dimethylethyl ester
Tani-0071613269-64-92-((1r,4r)-4-(tert-butoxycarbonyl(2-(tert-butoxycarbonylamino)ethyl)amino)cyclohexyl)acetic acid
Tani-0082407879-42-7tert-butyl 3-((R)-2-(2-((1r,4R)-4-((tert-butoxycarbonyl)(2-((tert-butoxycarbonyl)amino)ethyl)amino)cyclohexyl)acetamido)-2-((3aR,4R,6R,7aS)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)ethyl)-2-methoxybenzoate
Tani-00976308-28-6ethyl 2-((1r,4r)-4-aminocyclohexyl)acetate
Tani-01039684-80-5tert-butyl (2-bromoethyl)carbamate
Tani-0111613269-84-3ethyl 2-((1r,4r)-4-(2-(tert-butoxycarbonylamino)ethylamino)cyclohexyl)acetate
Tani-0121613269-62-7ethyl 2-((1r,4r)-4-(tert-butoxycarbonyl(2-(tert-butoxycarbonylamino)ethyl)amino)cyclohexyl)acetate
OptimisedRoute 2Steps 8 · Total yield /
Tani-00126507-91-5Tani-0022377377-83-6Tani-0032377377-87-0Tani-0041613269-60-5Tani-0062407879-41-6Tani-013189153-10-4Tani-0141613269-02-5Tani-0151613267-37-0Tani-01689711-08-0Tani-0171613269-16-1API · Taniborbactam
CodeCAS No.Intermediate
Tani-00126507-91-52-methoxy-3-methylbenzoic acid
Tani-0022377377-83-6tert-butyl 2-methoxy-3-methylbenzoate
Tani-0032377377-87-0tert-butyl 3-(bromomethyl)-2-methoxybenzoate
Tani-0041613269-60-5Benzoic acid, 3-[[(3aR,4R,6R,7aS)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]methyl]-2-methoxy-, 1,1-dimethylethyl ester
Tani-0062407879-41-6Benzoic acid, 3-[(2R )-2-amino-2-[(3aR ,4R ,6R ,7aS )-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl]-2- methoxy-, 1,1-dimethylethyl ester
Tani-013189153-10-42-((1r,4r)-4-(tert-butoxycarbonylamino)cyclohexyl)acetic acid
Tani-0141613269-02-5Benzoic acid, 3-[(2R)-2-[[2-[trans-4-[[(1,1-dimethylethoxy)carbonyl]amino]cyclohexyl]acetyl]amino]-2-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]ethyl]-2-methoxy-, 1,1-dimethylethyl ester
Tani-0151613267-37-0(S)-3-(2-((1r,4S)-4-aminocyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid
Tani-01689711-08-0tert-butyl (2-oxoethyl)carbamate
Tani-0171613269-16-1(S)-3-(2-((1r,4S)-4-(2-(tert-butoxycarbonylamino)ethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid

Frequently asked questions

What are the approved indications of Taniborbactam?

Approved indications include: Urinary tract infection, Pyelonephritis.

When does the Taniborbactam patent expire?

No public expiry year is available for Taniborbactam yet; this page updates once verified.

How many synthesis routes are recorded for Taniborbactam?

2 synthesis routes are recorded; the shortest is 8 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Taniborbactam intermediates?

All intermediates in Taniborbactam routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Taniborbactam intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-07